Product

JNT-517

Aliases

JNT-517 Suspension, JNT-517 Tablet

1 clinical trial

1 indication

Indication

Phenylketonuria

Clinical trial

A Phase 1, First-In-Human, Multiple Part, Single Ascending and Multiple Dose Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

Status: Recruiting, Estimated PCD: 2024-12-01